Nakao A - Search Results

1

Expression of the CD15 antigen in hepatocellular carcinoma.

Torii A, Nakayama A, Harada A, Nakao A, Nonami T, Sakamoto J, Watanabe T, Ito M, Takagi H. Torii A, et al. Among authors: nakao a. Cancer. 1993 Jun 15;71(12):3864-7. doi: 10.1002/1097-0142(19930615)71:12<3864::aid-cncr2820711212>3.0.co;2-5. Cancer. 1993. PMID: 7685236

2

Expression of HLA-DR in intrahepatic cholangiocarcinoma.

Torii A, Harada A, Nakao A, Nonami T, Nakayama A, Ito M, Takagi H. Torii A, et al. Among authors: nakao a. Cancer. 1992 Sep 1;70(5):1057-61. doi: 10.1002/1097-0142(19920901)70:5<1057::aid-cncr2820700508>3.0.co;2-e. Cancer. 1992. PMID: 1325267

3

Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus-strand and minus-strand viral RNA.

Takeda S, Shibata M, Morishima T, Harada A, Nakao A, Takagi H, Nagai Y. Takeda S, et al. Among authors: nakao a. Cancer. 1992 Nov 1;70(9):2255-9. doi: 10.1002/1097-0142(19921101)70:9<2255::aid-cncr2820700907>3.0.co;2-n. Cancer. 1992. PMID: 1327494

4

Results of hepatic resection and postoperative arterial chemotherapy for hepatocellular carcinoma.

Harada A, Nonami T, Kishimoto W, Nakao A, Takagi H. Harada A, et al. Among authors: nakao a. Cancer Chemother Pharmacol. 1992;31 Suppl:S35-7. doi: 10.1007/BF00687102. Cancer Chemother Pharmacol. 1992. PMID: 1333906 Clinical Trial.

5

Hepatic resection for hepatocellular carcinoma.

Suenaga M, Nakao A, Harada A, Nonami T, Okada Y, Sugiura H, Uehara S, Takagi H. Suenaga M, et al. Among authors: nakao a. World J Surg. 1992 Jan-Feb;16(1):97-104; discussion 104-5. doi: 10.1007/BF02067120. World J Surg. 1992. PMID: 1337806

6

[Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer].

Isshiki K, Nonami T, Kishimoto W, Katoh H, Akaza K, Harada A, Nakao A, Takagi H. Isshiki K, et al. Among authors: nakao a. Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 2):1634-7. Gan To Kagaku Ryoho. 1990. PMID: 2167638 Japanese.

7

Immunohistochemical localization of CA 19-9 and CEA in pancreatic carcinoma and associated diseases.

Ichihara T, Nagura H, Nakao A, Sakamoto J, Watanabe T, Takagi H. Ichihara T, et al. Among authors: nakao a. Cancer. 1988 Jan 15;61(2):324-33. doi: 10.1002/1097-0142(19880115)61:2<324::aid-cncr2820610223>3.0.co;2-q. Cancer. 1988. PMID: 3422034

8

Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma.

Inoue S, Nakao A, Harada A, Nonami T, Takagi H. Inoue S, et al. Among authors: nakao a. Am J Gastroenterol. 1994 Dec;89(12):2222-6. Am J Gastroenterol. 1994. PMID: 7526679

9

Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma.

Yasui M, Harada A, Torii A, Nakao A, Nonami T, Takagi H. Yasui M, et al. Among authors: nakao a. World J Surg. 1995 May-Jun;19(3):439-43. doi: 10.1007/BF00299186. World J Surg. 1995. PMID: 7639003

10

Partial hepatectomy for hepatocellular carcinoma in a patient with hemophilia: a case report.

Shen SC, Harada A, Kurokawa T, Nakao A, Nonami T, Isobe K, Imoto M, Takamatsu J, Takagi H. Shen SC, et al. Among authors: nakao a. Hepatogastroenterology. 1994 Jun;41(3):283-6. Hepatogastroenterology. 1994. PMID: 7959555

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,480 results

Search Page

Filters